Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 20% in 2021[12]. - The company's operating revenue for 2021 was CNY 577,454,609.38, representing a 40.63% increase compared to CNY 410,610,177.06 in 2020[18]. - The net profit attributable to shareholders for 2021 was CNY 85,262,276.58, a 31.77% increase from CNY 64,706,764.95 in 2020[18]. - The total assets at the end of 2021 were CNY 983,074,263.68, up 56.67% from CNY 627,487,556.52 at the end of 2020[18]. - The net assets attributable to shareholders at the end of 2021 were CNY 527,433,112.37, an increase of 103.62% from CNY 259,027,221.66 at the end of 2020[18]. - The basic earnings per share for 2021 was CNY 1.25, reflecting a 17.92% increase from CNY 1.06 in 2020[18]. - The total revenue for the year 2022 was 8,964,252 million, indicating a significant performance[104]. Dividend Distribution - The company plans to distribute a cash dividend of 3.00 RMB per 10 shares to all shareholders, based on a total of 81,752,500 shares[5]. - The proposed cash dividend for the year is 3.00 RMB per 10 shares, totaling 24,525,750.00 RMB[131]. - The cash dividend represents 100% of the total distributable profits for the year[129]. - The cash dividend distribution plan was approved by the board and complies with the company's articles of association[128]. Market Position and Strategy - The company is focusing on expanding its market presence and enhancing its product offerings through new technology development[12]. - The company aims to enhance energy efficiency in stenter machines, currently utilizing only 30% of input energy effectively, with plans to improve this through advanced heat recovery and energy optimization technologies[36]. - The company is positioned in the high-end equipment manufacturing sector, focusing on energy-saving and environmentally friendly textile machinery[27]. - The company aims to expand its domestic market share while actively exploring overseas markets, with a focus on becoming an international production service enterprise centered on the research, production, and sales of shaping machines[84]. Research and Development - The company has developed the "Y2088 series hot air stenter machine," recognized as a provincial industrial new product, and has received multiple accolades for its innovative products, including the "2021 Zhejiang Province first set of equipment" award for the "Y9000 dual-layer high-efficiency energy-saving digital stenter machine"[31][38]. - The company holds 141 patents, including 9 invention patents, and has been recognized as a national high-tech enterprise, indicating strong research and development capabilities[34][38]. - The company is committed to continuous R&D investment and has launched new products like the double-layer shaping machine to meet evolving customer needs[90]. - The company emphasizes the importance of innovation and customer feedback in guiding its R&D efforts to remain competitive in a technology-intensive industry[91]. Governance and Compliance - The company has established a governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and management team, ensuring compliance with relevant laws and regulations[95]. - The company maintains complete control over its assets, with no guarantees provided to shareholders or related parties, ensuring no asset or fund occupation by the controlling shareholder[96]. - The company has not reported any major changes in the fair value measurement of financial assets and liabilities[73]. - The company has not identified any risks during the supervisory activities of the supervisory board[122]. Share Structure and Ownership - The total number of shares increased from 61,312,500 to 81,752,500 after the issuance of 20,440,000 new shares[190]. - The largest shareholder, New Changxing Yuanwei Technology Co., Ltd., holds 55.43% of the shares, totaling 45,316,200 shares[191]. - The company has a total of 14,521 shareholders as of the end of the reporting period[191]. - The company has a total of 17,479,347 unrestricted shares, accounting for 21.38% of the total shares[1]. Risk Management - The company has identified major risks in its operations and outlined corresponding mitigation strategies in its future outlook section[5]. - The company faces risks from macroeconomic fluctuations that could impact downstream textile industry demand, which is crucial for its business[85]. - The company has identified risks related to raw material price fluctuations, particularly in steel, which could affect its gross margin if not managed effectively[89]. Employee and Management - The total number of employees at the end of the reporting period is 444, with 360 in the parent company and 84 in major subsidiaries[123]. - The company emphasizes the training of R&D talents and collaborates with key textile universities for technical exchanges and training[126]. - The company has established a performance evaluation system for technical personnel, linking their performance to salary adjustments and bonuses[125]. Transparency and Communication - The company is committed to maintaining transparency and has made its annual report available on multiple media platforms[15]. - The company ensured transparent communication with investors through multiple channels, maintaining the quality of information disclosure[141]. - The company is committed to maintaining transparency and accountability in its financial reporting and governance practices[104].
远信工业(301053) - 2021 Q4 - 年度财报